Table 4.

Stage 2 Adverse Events by treatment group^*

	CoQ10 2,700mg n=75	Placebo n=75
Patients with any AE	63 (84.0%)	64 (85.3%)
Fall	28 (37.3%)	17 (22.7%)
Pain	22 (29.3%)	19 (25.3%)
Nausea	13 (17.3%)	16 (21.3%)
Constipation	18 (24.0%)	10 (13.3%)
Diarrhea	8 (10.7%)	18 (24.0%)
Mood alteration	16 (21.3%)	7 (9.3%)
PEG placement	8 (10.7%)	10 (13.3%)
BIPAP/NIPPV	9 (12.0%)	6 (8.0%)
Edema: limb	8 (10.7%)	5 (6.7%)
Patients with dental AEs	4 (5.3%)	2 (2.7%)
Patients with AEs possibly related to treatment	32 (42.7%)	31 (41.3%)
Patients with any serious AE	18 (24.0%)	19 (25.3%)
Death	3 (4.0%)	5 (6.7%)

^*Events reported in more than 10% of patients in a single arm. AE follow-up is through 10 months.